This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The $3,659.72 firm fixed-price delivery order has a completion date of July 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the prime contractor, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 12:12 PM